Table 3.

Bortezomib and zoledronate maintenance after autologous HSCT

Bortezomib and zoledronate maintenance after autologous HSCT

SC indicates subcutaneous; IT, intensive therapy; NIT, nonintensive therapy; MV, multivariate; and ND, no difference.

Adapted from McCarthy et al.42 

Close Modal

or Create an Account

Close Modal
Close Modal